safranal has been researched along with urea in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bozkurt, MF; Fıdan, AF; Hazman, Ö; Karafakıoğlu, YS | 1 |
| Alakuş, H; Cellat, M; Etyemez, M; Güvenç, M; İşler, CT; Kutlu, T; Kuzu, M | 1 |
2 other study(ies) available for safranal and urea
| Article | Year |
|---|---|
Efficacy of safranal to cisplatin-induced nephrotoxicity.
Topics: Animals; Antineoplastic Agents; Cisplatin; Creatinine; Cyclohexenes; Drug Administration Schedule; Glutathione; Injections, Intraperitoneal; Kidney; Male; Malondialdehyde; Nephritis; Protective Agents; Rats; Rats, Sprague-Dawley; Renal Insufficiency; Terpenes; Urea | 2017 |
Investigation of the effects of safranal on the experimentally created rheumatoid arthritis model in rats.
Topics: Alanine; Animals; Antioxidants; Arthritis, Experimental; Arthritis, Rheumatoid; Aspartate Aminotransferases; C-Reactive Protein; Catalase; Creatinine; Cyclohexenes; Cyclooxygenase 2; Freund's Adjuvant; Glutathione; Glutathione Peroxidase; Interleukin-6; Malondialdehyde; Methotrexate; NF-kappa B; Rats; Terpenes; Tumor Necrosis Factor-alpha; Urea | 2022 |